2023-03-30T16:58:22+08:00 weekly 1.0 https://id.prisysbiotech.com/ 2024-11-10T06:44:06+08:00 weekly 0.9 https://id.prisysbiotech.com/animal-welfare 2024-11-10T06:44:02+08:00 weekly 0.9 https://id.prisysbiotech.com/translational-research-center 2024-11-10T06:44:12+08:00 weekly 0.9 https://id.prisysbiotech.com/cns-disorders-behavior-analysis 2024-11-10T06:44:03+08:00 weekly 0.9 https://id.prisysbiotech.com/ophthalmic-disease-research 2023-02-27T15:56:40+08:00 weekly 0.9 https://id.prisysbiotech.com/co-develop 2024-11-10T06:43:58+08:00 weekly 0.9 https://id.prisysbiotech.com/hematological-disease-research 2024-11-10T06:44:04+08:00 weekly 0.9 https://id.prisysbiotech.com/metabolic-syndromes-research 2024-11-10T06:44:05+08:00 weekly 0.9 https://id.prisysbiotech.com/respiratory-disease-research 2024-11-10T06:44:08+08:00 weekly 0.9 https://id.prisysbiotech.com/inflammation-immunology-disorders 2024-11-10T06:43:43+08:00 weekly 0.9 https://id.prisysbiotech.com/download 2024-09-29T14:45:25+08:00 weekly 0.9 https://id.prisysbiotech.com/nephrology 2024-09-29T14:23:03+08:00 weekly 0.9 https://id.prisysbiotech.com/fibrosis 2024-11-10T06:43:54+08:00 weekly 0.9 https://id.prisysbiotech.com/about-us 2024-11-10T06:43:54+08:00 weekly 0.9 https://id.prisysbiotech.com/contact-us 2023-04-01T09:44:52+08:00 weekly 0.9 https://id.prisysbiotech.com/newslist-1 2024-11-10T06:43:53+08:00 weekly 0.9 https://id.prisysbiotech.com/products 2026-02-07T02:37:28+08:00 weekly 0.9 https://id.prisysbiotech.com/blog/ 2023-04-01T09:44:43+08:00 weekly 0.9 https://id.prisysbiotech.com/translation-research/ 2023-04-01T09:44:43+08:00 weekly 0.9 https://id.prisysbiotech.com/safety-evaluation/ 2023-04-01T09:44:43+08:00 weekly 1.0 https://id.prisysbiotech.com/nhp-pharmacology/ 2023-04-01T09:44:47+08:00 weekly 0.9 https://id.prisysbiotech.com/pk-pd-adme/ 2023-04-01T09:44:47+08:00 weekly 0.9 https://id.prisysbiotech.com/biosafety-research/ 2024-04-09T19:38:19+08:00 weekly 0.9 https://id.prisysbiotech.com/clearpoint/ 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/safety-evaluation/single-dose-repeated-dose-toxicity-testing.html 2024-11-10T06:43:56+08:00 weekly 0.8 https://id.prisysbiotech.com/pk-pd-adme/toxicokinetics.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/non-human-primate.html 2024-11-10T06:43:55+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/nhp-asthma-atopic-dermatitis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/what-is-a-nhp-study.html 2024-11-10T06:43:51+08:00 weekly 0.8 https://id.prisysbiotech.com/safety-evaluation/dose-range-finding-test.html 2024-11-10T06:43:56+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/psoriasis-nonhuman-primates-disease-model.html 2024-11-10T06:43:55+08:00 weekly 0.8 https://id.prisysbiotech.com/pk-pd-adme/pharmacokinetics.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/safety-evaluation/new-and-modified-applications.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/safety-evaluation/toxicology.html 2024-11-10T06:43:53+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/nhp-non-alcoholic-steatohepatitis-nash-model.html 2024-11-10T06:43:55+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/hemophilia-a-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/non-human-primate-model-renal-ischemia.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/glaucoma-nonhuman-primates-disease-model.html 2024-11-10T06:43:48+08:00 weekly 0.8 https://id.prisysbiotech.com/translation-research/nhpresources.html 2024-11-10T06:43:58+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/tdar-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/heart-failure-nonhuman-primates-disease-model.html 2024-11-10T06:43:53+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/delayed-type-hypersensitivity-dth-nonhuman.html 2024-11-10T06:43:57+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/rheumatoid-arthritis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/translation-research/translational-studies.html 2024-11-10T06:44:01+08:00 weekly 0.8 https://id.prisysbiotech.com/pk-pd-adme/pharmacodynamics.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/amd-nonhuman-primates-disease-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/pk-pd-adme/adme.html 2024-11-10T06:43:56+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/nhp-lung-fibrosis-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/myopia-hyperopia-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/nhp-chronic-obstructive-pulmonary-disease.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/multiple-sclerosis-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/coagulation-hemostasis-nonhuman-primates.html 2024-11-10T06:43:59+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/nhp-monkey-disease-models.html 2024-11-10T06:43:53+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/epilepsy-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/embolism-nonhuman-primates-disease-model.html 2024-11-10T06:43:54+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/mcao-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/safety-evaluation/immunotoxicity.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-nhp-disease-model.html 2024-11-10T06:43:55+08:00 weekly 0.8 https://id.prisysbiotech.com/biosafety-research/biosafetyresearch.html 2024-11-10T07:10:40+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/the-nhp-pharmacology-of-prisys.html 2024-11-10T06:43:57+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/neuropathic-pain-nhp-model.html 2023-03-30T05:20:23+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/uveitis-nonhuman-primates-disease-model.html 2024-11-10T06:44:12+08:00 weekly 0.8 https://id.prisysbiotech.com/clearpoint/clearpoint-navigation-for-cns-research.html 2024-11-10T07:10:05+08:00 weekly 0.8 https://id.prisysbiotech.com/translation-research/ai-based-nhp-behavior-analysis-system.html 2024-11-10T06:43:49+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/parkinson-s-disease-model.html 2024-11-10T06:44:24+08:00 weekly 0.8 https://id.prisysbiotech.com/translation-research/clinical-imaging.html 2024-10-04T08:22:46+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/hyperlipoidemia-model.html 2024-10-04T08:22:47+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/type-1-diabetes-mellitus-model.html 2024-10-04T08:22:47+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/a-v-shunt-model.html 2024-11-10T06:43:50+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/type-2-diabetes-mellitus-model.html 2024-10-04T08:22:48+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/immunosuppression-model.html 2024-10-04T08:22:49+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/endometriosis-model.html 2024-10-04T08:23:04+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/renal-fibrosis-model.html 2024-12-07T16:11:31+08:00 weekly 0.8 https://id.prisysbiotech.com/clearpoint/nhp-neuroscience.html 2024-12-07T17:07:43+08:00 weekly 0.8 https://id.prisysbiotech.com/clearpoint/convection-enhanced-delivery-ced-technology.html 2025-04-01T19:11:32+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/atopic-dermatitis-nhp-model.html 2025-04-01T19:48:55+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/pruritus-nhp-model.html 2025-07-24T18:35:14+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/inflammatory-bowel-disease-ibd-nhp-model.html 2025-07-24T18:35:21+08:00 weekly 0.8 https://id.prisysbiotech.com/translation-research/targeted-organ-drug-delivery-platform-in-nhp.html 2025-08-25T07:12:01+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/aav-synuclein-overexpression-nhp-model.html 2025-09-14T23:52:45+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/heart-failure-nhp-model.html 2025-09-22T05:52:58+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/acute-lung-inflammation-ali-nhp-model.html 2025-09-30T08:32:22+08:00 weekly 0.8 https://id.prisysbiotech.com/pk-pd-adme/nose-to-brain-drug-delivery.html 2025-10-06T19:23:02+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/acute-hemorrhagic-shock-model-nhp-model.html 2025-12-25T20:45:01+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/retinitis-pigmentosa-rp-nhp-model.html 2026-01-29T22:44:18+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/liver-fibrosis-model.html 2026-04-30T18:10:48+08:00 weekly 0.8 https://id.prisysbiotech.com/translation-research/dsa-guided-interventional-platform.html 2026-04-30T18:10:54+08:00 weekly 0.8 https://id.prisysbiotech.com/pk-pd-adme/nhp-intracerebral-injection-icm-services.html 2026-04-30T18:10:50+08:00 weekly 0.8 https://id.prisysbiotech.com/pk-pd-adme/nhp-intrathecal-dosing-csf-sampling.html 2026-04-30T18:10:41+08:00 weekly 0.8 https://id.prisysbiotech.com/translation-research/biodistribution-imaging-service.html 2026-05-25T18:25:55+08:00 weekly 0.8 https://id.prisysbiotech.com/nhp-pharmacology/nhp-focal-segmental-glomerulosclerosis-fsgs.html 2026-05-25T18:25:56+08:00 weekly 0.8 https://id.prisysbiotech.com/pk-pd-adme/nhp-intracerebroventricular-icv-injection.html 2023-04-01T09:44:43+08:00 weekly 0.9 https://id.prisysbiotech.com/newslist-714422-1 2023-04-01T09:44:44+08:00 weekly 0.9 https://id.prisysbiotech.com/newslist-714423-1 2024-08-03T04:04:50+08:00 weekly 0.9 https://id.prisysbiotech.com/newslist-819948-1 2026-04-30T18:10:33+08:00 weekly 0.9 https://id.prisysbiotech.com/newslist-17852908714304512-1 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-sot2023-66137861.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/meetprisys-sot2023-66137862.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/the-construction-of-prisys-shanghai-nhp-r-d-ce-66137863.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/gene-therapy-nhp-model-66137864.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/do-we-need-further-studies-for-pain-assessment-66137865.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/supporting-women-s-health-a-look-into-endomet-66137866.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-biotech-non-human-primate-pharmacology-66137867.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/top-10-popular-questions-related-to-gene-thera-66137868.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/dmpk-study-for-gene-therapy-66137874.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-celebrating-world-wildlife-day-66138778.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/gene-therapy-toxicology-66275734.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/unlocking-the-potential-of-nonhuman-primates-67573909.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/unleashing-the-therapeutic-potential-67573910.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/celebrating-world-day-for-laboratory-animals-67575870.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/world-parkinsons-disease-day-67575872.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/how-nonhuman-primates-can-revolutionize-sirna-67576691.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/maximizing-crispr-cas9-research-efficiency-wit-67579528.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-effectively-in-gene-therapy-67579529.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/maximizing-sirna-pharmacology-efficiency-67587875.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/revolutionizing-drug-discovery-nhp-68131710.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/why-you-should-care-about-non-human-primates-68131711.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/meet-prisys-biotech-at-70th-jalas-68131713.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/gene-therapy-shines-with-new-approvals-for-rar-68131719.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/an-optimal-animal-model-of-ischemic-stroke-est-68333672.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-biotech-showcases-non-human-primate-mod-69262953.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/how-aav-gene-therapy-can-save-your-vision-the-69262954.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/what-are-lipid-nanoparticles-for-gene-therapy-69262957.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/immunotoxicity-test-drug-safety-evaluation-pr-69262958.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-biotech-invites-you-to-participate-in-t-69262963.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/the-promising-future-of-aav-gene-therapy-in-no-69263826.html 2023-07-16T21:45:50+08:00 weekly 0.8 https://id.prisysbiotech.com/news/large-animal-experiment-public-service-platfor-69309300.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/how-china-monkey-help-to-conduct-preclinical-r-69309347.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/how-to-lose-weight-and-control-diabetes-with-g-69309349.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/what-is-the-efficiency-of-rnai-69309391.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-biotechnology-a-leader-in-nhp-cns-dise-69663590.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/key-research-points-of-adc-drug-pk-69664275.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/method-for-establishing-a-cynomolgus-monkey-mo-71007201.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/0-71007428.html 2023-09-14T13:35:59+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-providing-high-quality-animal-experime-71007430.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pharmacology-main-parameters-and-significance-71007432.html 2023-09-14T14:05:19+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pharmacokinetics-research-strategies-and-case-71008778.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/preclinical-pharmacology-evaluation-of-oncolyt-71009091.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-biotech-invites-you-to-attend-sapa-chin-72336688.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-macaque-animal-mod-72336689.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/meet-prisys-biotech-at-the-society-for-neurosc-72336691.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/world-alzheimer-s-day-the-challenges-and-sol-72336692.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/world-stroke-day-focus-on-ischemic-stroke-an-72336693.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/exhibition-review-prisys-biotech-shines-at-t-72715750.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/non-human-primates-a-brief-introduction-to-th-73033226.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/guidelines-for-lifetime-use-of-nonhuman-primat-73837331.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/how-ultrasound-guided-liver-biopsy-enhances-ma-73837334.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/revolutionizing-cns-drug-delivery-prisys-and-74278341.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/elevating-nucleic-acid-therapeutics-through-cu-74707188.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-advancing-animal-experimentation-throu-74818565.html 2024-11-10T06:43:50+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nonhuman-primate-study-newsletter-2024-q-75178015.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/non-clinical-pharmacodynamics-research-an-ess-75178019.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-achieves-full-accreditation-from-aaalac-76250068.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/innovative-solutions-for-advancing-respiratory-77095023.html 2024-11-10T06:43:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-biotech-2024-q2-newsletter-77799476.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/mri-guided-large-animal-central-nervous-system-77799478.html 2024-11-10T06:43:49+08:00 weekly 0.8 https://id.prisysbiotech.com/news/direct-delivery-of-oligonucleotide-drugs-to-th-79205805.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-asthma-model-79205806.html 2024-11-10T06:43:46+08:00 weekly 0.8 https://id.prisysbiotech.com/news/non-na-ve-nhps-in-preclinical-trials-a-cost-e-79205808.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/advancing-immunology-and-inflammation-research-79205817.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/intra-cerebrovascular-stroke-ich-model-prisys-79205826.html 2024-11-10T06:43:49+08:00 weekly 0.8 https://id.prisysbiotech.com/news/revolutionizing-cns-drug-development-prisys-b-79549136.html 2024-11-10T06:43:50+08:00 weekly 0.8 https://id.prisysbiotech.com/news/cynomolgus-monkey-in-ophthalmic-drug-research-79549137.html 2024-11-10T06:43:51+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-nhp-models-immunology-inflammatio-79549138.html 2024-11-10T06:43:46+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pk-strategies-of-pdc-79568265.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/preclinical-animal-studies-1-animal-specie-79568266.html 2024-11-10T06:44:00+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nonclinical-safety-evaluation-of-ocular-drug-d-79568267.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/the-role-of-aav-in-gene-therapy-immune-respon-79568268.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/reducing-the-use-of-nonhuman-primates-in-noncl-79568269.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/clinical-pathology-data-interpretation-challen-79568270.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/optimized-nonclinical-immunogenicity-evaluatio-79568271.html 2024-11-10T06:43:51+08:00 weekly 0.8 https://id.prisysbiotech.com/news/integrating-cns-safety-evaluation-into-79568272.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79568273.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/adme-insights-for-oligonucleotide-drugs-79568274.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/reflections-on-non-clinical-pharmacology-studi-79568275.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/non-human-primate-cerebrospinal-fluid-collecti-79568276.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/preclinical-animal-studies-2-routes-and-vo-79568277.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/how-to-evaluate-preclinical-pharmacological-ef-79568278.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/how-to-conduct-preclinical-pharmacology-toxico-79568279.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/insight-into-the-sensory-and-behavioral-traits-79568280.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/key-points-in-designing-strategies-for-non-79568281.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/advancing-cns-and-cgt-research-prisys-biotech-79568282.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/how-to-evaluate-the-safety-of-skin-products-be-79568283.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/revolutionizing-metabolic-disease-treatment-a-79568284.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nonclinical-study-evaluation-q-a-79568285.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/the-vital-role-of-experimental-monkeys-in-adva-79568286.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/application-prospects-of-gene-drugs-based-on-l-79568287.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/advancing-sirna-therapeutics-overcoming-chall-79568288.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/how-to-develop-new-drugs-faster-and-safer-a-g-79568289.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/the-significant-role-of-experimental-monkeys-i-79568290.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/group-housing-guidelines-for-laboratory-monkey-79568291.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/liver-toxicity-as-a-key-concern-for-sirna-drug-79568292.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-biotechnology-novel-lipid-nanoparticle-79568293.html 2024-11-10T06:43:52+08:00 weekly 0.8 https://id.prisysbiotech.com/news/understanding-macaca-fascicularis-cynomolgus-79568294.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/how-drugs-move-and-change-in-our-bodies-a-bri-79568295.html 2024-11-10T06:43:46+08:00 weekly 0.8 https://id.prisysbiotech.com/news/the-importance-of-translational-medicine-resea-79568296.html 2024-11-10T06:43:58+08:00 weekly 0.8 https://id.prisysbiotech.com/news/considerations-for-interpreting-clinical-patho-79568297.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/chinese-scientists-offers-new-strategies-to-re-79568298.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/significance-principles-and-requirements-of-79568299.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/how-to-deliver-biologics-to-the-brain-79568300.html 2024-11-10T06:43:49+08:00 weekly 0.8 https://id.prisysbiotech.com/news/the-main-factors-considered-in-woe-analysis-79568301.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79568302.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/factors-to-consider-for-the-immunogenicity-of-79568303.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pharmacodynamic-pd-evaluation-of-gene-therap-79568304.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/brief-introduction-about-biological-analysis-o-79568305.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pharmacokinetics-and-bioanalysis-of-oligonucle-79568306.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/mrna-based-therapies-future-and-challenges-79568307.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/mrna-based-therapies-present-79568309.html 2024-11-10T06:43:47+08:00 weekly 0.8 https://id.prisysbiotech.com/news/mrna-based-therapies-past-79568310.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/lcms-preclinical-bioanalysis-of-lnp-based-gene-79568311.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/mrna-a-powerful-and-versatile-tool-for-fighti-79568312.html 2024-08-07T08:44:42+08:00 weekly 0.8 https://id.prisysbiotech.com/news/advancements-in-cns-research-ced-imri-79656503.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/advanced-cns-delivery-techniques-in-cynomolgus-81313953.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/intranasal-administration-in-animal-studies-81313954.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/animal-models-of-human-diseases-81313955.html 2024-11-10T06:43:49+08:00 weekly 0.8 https://id.prisysbiotech.com/news/convection-enhanced-delivery-81313956.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/innovations-in-pain-evaluation-ai-driven-beha-81313957.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/cynomolgus-monkey-chronic-kidney-disease-model-81313958.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/human-disease-animal-models-81313959.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/dmpk-evaluation-of-central-nervous-system-cns-81313960.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/china-experimental-monkey-industry-81313962.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/cynomolgus-monkey-mcao-model-81313965.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/compartment-pk-model-81313966.html 2024-11-10T07:10:01+08:00 weekly 0.8 https://id.prisysbiotech.com/news/the-importance-of-preclinical-pharmacodynamics-81314014.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/rtimri-for-parkinsons-disease-81314015.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/advances-in-mrna-pulmonary-delivery-systems-an-82297499.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/understanding-the-dmpk-of-adc-drugs-82742858.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pharmacodynamics-evaluation-of-adcs-82742859.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-biotech-establishes-cynomolgus-monkey-p-82742860.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pharmacokinetic-pk-considerations-for-centra-82742861.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pharmacokinetics-evaluation-of-antibody-drug-c-82742862.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/comprehensive-preclinical-safety-evaluation-of-82742863.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/2024-nobel-prize-in-physiology-or-medicine-82742870.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/progress-in-the-development-of-nucleic-acid-dr-82742871.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/comprehensive-non-human-primate-models-for-ren-82742875.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/drug-delivery-strategies-for-brain-diseases-83021515.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/real-time-intraoperative-mri-navigation-suppo-83023441.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/ocular-toxicity-studies-of-eye-drops-drug-exp-83034042.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/the-critical-role-of-animal-models-in-human-di-83983825.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/minipig-as-nonclinical-large-animal-83983826.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/advancing-rheumatoid-arthritis-ra-research-w-83983827.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/potential-routes-for-biologics-to-brain-83983828.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-annual-report-2024-advancing-nhp-model-83983830.html 2025-01-18T12:05:44+08:00 weekly 0.8 https://id.prisysbiotech.com/news/parkin-gene-deficiency-monkey-model-reveals-ne-83983870.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nonclinical-drug-development-guide-toxicity-83983898.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nasal-to-brain-n2b-drug-delivery-83983901.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/animal-models-for-atopic-dermatitis-83985375.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/meet-prisys-in-2025-us-roadshow-17243431015769088.html 2025-02-26T22:08:15+08:00 weekly 0.8 https://id.prisysbiotech.com/news/selecting-the-ideal-non-human-primate-for-toxi-17243463742284800.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/animal-models-challenges-and-applications-in-17295243308082176.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/animal-brain-stereotactic-instruments-17295243313144832.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/non-human-primate-model-for-rheumatoid-arthrit-17295243315127296.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/systemic-lupus-erythematosus-sle-and-the-rol-17295243343275008.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/integration-of-pharmacokinetics-and-pharmacody-17295243347747840.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/animal-models-for-womens-health-17295243357037568.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-biotech-s-cynomolgus-monkey-psoriasis-m-17295243366147072.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/cynomolgus-monkey-endometriosis-model-17295243379303424.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/microbial-testing-and-its-impact-on-nhp-17295243447477248.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/animal-models-for-in-vivo-testing-1-establi-17295243593655296.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/liver-biopsy-a-crucial-technique-in-large-ani-17295243600339968.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/what-does-proof-of-concept-poc-in-drug-devel-17295243630896128.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pharmacokinetics-of-inhaled-drugs-17295243636515840.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/membranous-nephropathy-model-17295243656881152.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/world-obesity-day-nhp-metabolic-models-17295243708310528.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nonclinical-pharmacodynamic-research-17295244008006656.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nonclinical-immunotoxicity-assessment-strateg-17295425752343552.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/targeting-interleukin-31-autoimmune-disease-17298504182686720.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/advancing-parkinson-s-disease-research-with-th-17374214278439936.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/intrathecal-it-injection-a-direct-cns-deliv-17374214314370048.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/aso-pharmacokinetics-absorption-17374214320137216.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pharmacokinetics-pk-key-parameters-17374214360556544.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/advanced-preclinical-inhalation-studies-techn-17374214374056960.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/asthma-research-why-non-human-primate-models-17374214376973312.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/atopic-dermatitis-how-cynomolgus-monkey-model-17374214399353856.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/intracerebroventricular-icv-injection-17374214471050240.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/preclinical-pk-pd-studies-nhp-models-17374214699279360.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/designing-animal-studies-key-considerations-f-17374214715991040.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-inhalation-studies-for-biologics-prisys-17374214909043712.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/intracerebral-icm-injection-precision-targe-17374259828696064.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/cynomolgus-monkey-pain-models-17456583828972544.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-biotech-s-nhp-atopic-dermatitis-model-f-17456583834526720.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/engineered-exosomes-revolutionizing-drug-deli-17456583877288960.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/guiding-principles-for-animal-species-selectio-17456583890084864.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-model-platforms-to-support-drug-developmen-17456584030217216.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-biotech-2025-mid-year-review-17456584086217728.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-pain-models-accelerating-analgesic-drug-d-17456584220746752.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-biotech-s-advanced-dsa-and-imri-for-hem-17456584336679936.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/advancing-atopic-dermatitis-research-prisys-b-17456584620467200.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/respiratory-therapies-prisys-biotech-s-integr-17456584798217216.html 2025-07-24T18:56:34+08:00 weekly 0.8 https://id.prisysbiotech.com/news/a-guide-to-anti-drug-antibody-ada-assessment-17456596490953728.html 2025-07-24T18:56:39+08:00 weekly 0.8 https://id.prisysbiotech.com/news/key-considerations-for-dosing-volume-17456597263393792.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-acute-hemorrhage-model-17501175013221376.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pruritus-research-il-31-nhp-itch-model-17501175067124736.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-copd-model-17501175127680000.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/preclinical-dosing-guidelines-iv-po-volume-17501175135511552.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/serum-vs-plasma-choosing-the-optimal-matrix-17501175175554048.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-pain-models-for-translational-drug-discove-17501175224148992.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/idiopathic-pulmonary-fibrosis-ipf-nhp-model-17530506097517568.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/adc-drug-development-translational-pk-pd-fra-17530506103137280.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/the-importance-of-administration-volume-17530506129024000.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/cynomolgus-monkey-biodistribution-study-17530506137953280.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/meet-prisys-biotech-at-upcoming-eu-roadshow-17530506324206592.html 2025-09-15T00:32:03+08:00 weekly 0.8 https://id.prisysbiotech.com/news/brain-targeted-drug-delivery-17530530008523776.html 2025-09-15T00:32:13+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-models-for-hematology-and-stroke-17530530284053504.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/cynomolgus-rhesus-monkey-models-prisys-bio-17540769025827840.html 2025-10-06T19:23:33+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-based-pharmacology-and-pharmacodynamic-17561364404020224.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/shr-2004-a-breakthrough-in-vte-prevention-for-17642687520695296.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nasal-to-brain-n2b-delivery-technology-for-c-17642687619982336.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/cold-allodynia-pain-model-in-cynomolgus-monkey-17642687688008704.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-ai-based-behavioral-analysis-17642687721858048.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/th17-driven-nhp-immunology-models-17642687782347776.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/rfp-template-for-nhp-studies-17642687847064576.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/mri-guided-intracerebral-drug-delivery-17642687872672768.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/ai-based-nhp-behavioratlas-system-3d-behavi-17642687878177792.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pk-study-targeted-drug-delivery-17642687940518912.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-respiratory-disease-models-and-airway-drug-17642688123397120.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-renal-biopsy-17642689144759296.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/translational-car-t-evaluation-in-vitro-17674685675234304.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/parkinsons-disease-preclinical-models-17674685855671296.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/ai-driven-markerless-3d-behavioral-analysis-17674690160239616.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/high-precision-drug-delivery-and-ai-driven-nhp-17674702287873024.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/how-to-choose-a-reliable-preclinical-cro-key-17674702311547904.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/lps-induced-acute-lung-inflammation-ali-nhp-17674702327981056.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/one-to-multi-compartment-pk-models-17674710324356096.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/hdm-seb-induced-atopic-dermatitis-atd-model-17674710377702400.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/cns-drug-candidates-in-preclinical-study-17674710403736576.html 2026-01-29T22:45:33+08:00 weekly 0.8 https://id.prisysbiotech.com/news/imri-guided-brain-drug-delivery-17724352149316608.html 2026-01-29T22:46:41+08:00 weekly 0.8 https://id.prisysbiotech.com/news/non-human-primate-mash-associated-liver-fibros-17724353167057920.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/non-human-primate-models-are-critical-cns-17724372668392448.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/multi-endpoint-pain-assessment-the-future-17724372718461952.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/blood-sampling-time-point-in-pharmacokinetic-17724372841538560.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pk-statistical-analysis-nca-parameters-guide-17724372842292224.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/uric-acid-metabolism-in-humans-vs-monkeys-17724372851975168.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/emotional-memory-chronic-pain-nhp-models-17724372903486464.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/analgesics-fail-in-preclinical-measure-pain-17724372927079424.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/2025-recap-how-prisys-is-redefining-translati-17724372934353920.html 2026-04-30T18:10:35+08:00 weekly 0.8 https://id.prisysbiotech.com/news/drug-development-reliance-on-nhp-models-17852908807922688.html 2026-04-30T18:10:43+08:00 weekly 0.8 https://id.prisysbiotech.com/news/ipf-drug-development-nhp-ct-imaging-pft-17852908826928128.html 2026-04-30T18:10:42+08:00 weekly 0.8 https://id.prisysbiotech.com/news/mri-guided-cns-delivery-in-nhp-models-17852908886746112.html 2026-04-30T18:10:49+08:00 weekly 0.8 https://id.prisysbiotech.com/news/translational-pk-pd-framework-cynomolgus-17852908949300224.html 2026-04-30T18:10:40+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-cns-biodistribution-studies-intrathecal-17852908972516352.html 2026-04-30T18:10:43+08:00 weekly 0.8 https://id.prisysbiotech.com/news/ai-markerless-nhp-3d-behavior-analysis-system-17852909034742784.html 2026-04-30T18:10:38+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pet-ct-biodistribution-in-nhp-models-for-cns-17852909154509824.html 2026-04-30T18:10:46+08:00 weekly 0.8 https://id.prisysbiotech.com/news/large-animal-radiolabeling-and-in-vivo-imaging-17852909165093888.html 2026-04-30T18:10:40+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-av-shunt-thrombosis-model-antibody-safety-17852909213606912.html 2026-04-30T18:10:59+08:00 weekly 0.8 https://id.prisysbiotech.com/news/evaluating-dmpk-properties-17852909238330368.html 2026-04-30T18:11:02+08:00 weekly 0.8 https://id.prisysbiotech.com/news/dopamine-transporter-pet-imaging-in-nhp-models-17852909287072768.html 2026-04-30T18:10:49+08:00 weekly 0.8 https://id.prisysbiotech.com/news/in-vivo-immune-cell-tracking-17852909355508736.html 2026-04-30T18:10:49+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nonlinear-pharmacokinetics-nhp-pkpd-17852909393060864.html 2026-04-30T18:10:44+08:00 weekly 0.8 https://id.prisysbiotech.com/news/non-glp-pharmacology-data-integrity-17852909398074368.html 2026-04-30T18:10:53+08:00 weekly 0.8 https://id.prisysbiotech.com/news/prisys-supports-ind-approval-of-ux-gip001-17852909441590272.html 2026-04-30T18:10:44+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nonclinical-pharmacokinetics-strategy-17852909443146752.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/nhp-models-translational-drug-development-17888325525316608.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pk-data-as-translational-biomarker-17888325560394752.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/non-human-primate-models-of-pulmonary-fibrosis-17888325562295296.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/on-demand-webinar-mri-ced-nhp-17888325639808000.html 2026-05-30T00:32:45+08:00 weekly 0.8 https://id.prisysbiotech.com/news/pk-data-as-pharmacodynamic-biomarker-17888325665268736.html 2026-02-06T06:16:55+08:00 weekly 0.8 https://id.prisysbiotech.com/blog/how-do-nhp-preclinical-studies-help-in-the-development-of-geriatric-drugs-2844578.html 2026-02-12T04:51:27+08:00 weekly 0.8 https://id.prisysbiotech.com/blog/how-are-nhps-selected-for-a-study-2921463.html 2026-02-27T06:19:51+08:00 weekly 0.8 https://id.prisysbiotech.com/blog/what-are-the-advantages-of-using-an-nhp-cro-3016066.html 2026-03-03T06:29:07+08:00 weekly 0.8 https://id.prisysbiotech.com/blog/what-is-the-pharmacokinetic-profile-of-inhaled-drugs-3053038.html 2026-03-10T06:10:54+08:00 weekly 0.8 https://id.prisysbiotech.com/blog/how-do-pd-drugs-influence-the-immune-cells-in-the-brain-in-pharmacology-3122306.html 2026-03-24T05:34:31+08:00 weekly 0.8 https://id.prisysbiotech.com/blog/how-to-measure-the-infarct-volume-in-the-mcao-nhp-model-3321686.html 2026-04-24T07:01:49+08:00 weekly 0.8 https://id.prisysbiotech.com/blog/pk-pd-clinical-implications-3748810.html 2026-05-18T04:52:20+08:00 weekly 0.8 https://id.prisysbiotech.com/blog/nhp-preclinical-studies-drug-development-significance-4028209.html